Bausch + Lomb Corporation officially introduced PreserVision AREDS3 Eye Vitamins to the United States market. This brand-new formula combines clinically proven AREDS2 nutrients with a unique B-vitamin complex. The National Eye Institute originally recommended these core nutrients. They slow down the progression of moderate-to-advanced age-related macular degeneration.
Age-related macular degeneration affects approximately 28 million people in the United States. It remains the leading cause of vision loss among older Americans. This progressive condition impacts central vision in one or both eyes. People struggle with daily activities like driving and reading. They also have difficulty recognizing the faces of loved ones.
Triple‑Action Support for Macular Health
The advanced PreserVision AREDS3 Eye Vitamins formula supports a broader range of individuals. Patients in earlier stages of the condition can now access early nutritional support. The formula protects macular health by neutralizing free radicals. It also replenishes the natural filter of your eyes.
The unique B-vitamin complex contains thiamin, riboflavin, niacin, and pantothenic acid. It also includes vitamin B6, biotin, folate, and vitamin B12. These specific ingredients promote healthy cellular eye function. Furthermore, the new formula delivers two times better absorption of key nutrients.
“AMD affects millions of people, often long before symptoms meaningfully change day-to-day life,” said John Ferris, president, Consumer, Bausch + Lomb. “Historically, options to support macular health earlier in the condition have been limited. PreserVision AREDS3 reflects decades of research, and our commitment to advancing eye health through science, offering an option for a broader range of people looking to support their macular health.”
Scientific evidence from more than 20 human studies guided this new development. The research involved nearly 30,000 individuals over two decades. The Women’s Antioxidant and Folic Acid Cardiovascular Study showed excellent results. It found a statistically significant association between specific B-vitamin supplementation and reduced risk.
“Nutritional support for AMD management has to evolve as the science evolves,” said Julie Poteet, OD, MS, CNS. “PreserVision AREDS3 eye vitamins reflect the most current thinking in nutritional support for macular health, building on the established AREDS2 nutrients and incorporating a unique B-vitamin complex backed by more than two decades of scientific research on B vitamins.2 That matters in practice, because it gives me greater confidence and flexibility when discussing nutritional options with a broader group of patients, including those in earlier stages.”
A future long-term clinical trial is already in the planning stages. Currently, consumers can find PreserVision AREDS3 Eye Vitamins at most retailers nationwide.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
